© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Videos
Facing COVID-19's Challenges to Care for the Caregiver
September 22, 2020
When the coronavirus disease 2019 (COVID-19) pandemic prevented Christie M. Santure, BSN, RN, OCN, from hosting her caregiver support group, she quickly adapted and switched to a virtual format.
Diarrhea Management in HER2+ Breast Cancer
September 14, 2020
Oncology nurses need to keep an eye out for diarrhea in their patients on CDK4/6 inhibitors.
Forged Through Fire: Nurses Are More Needed Than Ever Before
September 01, 2020
Great men and women are forged through fire, so people who are passionate about health care should not put a nursing degree on hold because of the COVID-19 pandemic.
Immunotherapy Moves to SCLC, But Chemotherapy Is Still a Mainstay
August 28, 2020
Small cell lung cancer is very sensitive to chemotherapy, but immunotherapy offers another line of treatment for when chemotherapy stops working.
Trial To Evaluate Eprenetapopt-Azacytidine Combo in TP53+ MDS Completes Enrollment
June 18, 2020
A phase 3 trial designed to evaluate eprenetapopt plus azacytidine (Vidaza) in patients with TP53-mutant positive myelodysplastic syndrome (MDS) completed full enrollment, according to Aprea Therapeutics, Inc.
Tivozanib Tolerability Shows Potential Advantage for Patients with Advanced RCC
May 20, 2020
Oncology Nursing News sat down with Brian Rini, MD, from the Vanderbilt-Ingram Cancer Center (VICC), to discuss results from the phase III TIVO03 trial, and its potential impact on patients with relapsed or refractory renal cell carcinoma.
Patient Education for Oral Therapies Is Crucial
April 29, 2020
There is far less patient education for oral agents, such as CDK4/6 inhibitors for breast cancer, as there is for chemotherapy. This is a major issue, explained Patricia Jakel, MN, RN, AOCN, advanced practice nurse at UCLA's solid tumor program and co-editor in chief of Oncology Nursing News.
Don't Shy Away from the Sex Talk With Cancer Survivors
April 23, 2020
The availability of evidence-based research may help make clinicians more comfortable discussing sexual issues with cancer survivors.
Struggles in Full Biomarker Testing for Lung Cancer
April 16, 2020
With minimally invasive procedures to test lung cancer tumors, there often isn't enough tissue to undergo a full biomarker test, pointing toward the strength of liquid biopsies, explained Lynette M. Sholl, MD, chief of thoracic pathology at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and associate professor at Harvard Medical School.